GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Issuance of Debt

Beacon Pharmaceuticals (DHA:BEACONPHAR) Issuance of Debt : BDT5,257 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals Issuance of Debt?

Beacon Pharmaceuticals's Issuance of Debt for the three months ended in Dec. 2023 was BDT2,125 Mil.

Beacon Pharmaceuticals's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was BDT5,257 Mil.

Beacon Pharmaceuticals Issuance of Debt Historical Data

The historical data trend for Beacon Pharmaceuticals's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals Issuance of Debt Chart

Beacon Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Issuance of Debt
Get a 7-Day Free Trial 158.03 473.11 315.79 1,329.78 3,628.33

Beacon Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.16 2,115.72 979.92 36.33 2,125.34

Beacon Pharmaceuticals Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5,257 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beacon Pharmaceuticals Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beacon Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Issuance of Debt
Comparable Companies
DHA:BXPHARMA DHA:ACMELAB DHA:ORIONINFU DHA:TECHNODRUG DHA:ASIATICLAB DHA:CENTRALPHL DHA:RENATA ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692
Traded in Other Exchanges
N/A
Address
9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223
Website
https://www.beaconpharma.com.bd
Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals Headlines

No Headlines